Philip D Adamson1, Amanda Hunter2, Debbie M Madsen2, Anoop S V Shah2, David A McAllister2, Tania A Pawade2, Michelle C Williams2, Colin Berry2, Nicholas A Boon2, Marcus Flather2, John Forbes2, Scott McLean2, Giles Roditi2, Adam D Timmis2, Edwin J R van Beek2, Marc R Dweck2, Hans Mickley2, Nicholas L Mills2, David E Newby2. 1. From the British Heart Foundation Centre for Cardiovascular Science (P.D.A., A.H., A.S.V.S., T.A.P., N.A.B., E.J.R.v.B., M.R.D., N.L.M., D.E.N.) and Clinical Research Imaging Centre (M.C.W.), University of Edinburgh, United Kingdom; Department of Cardiology, Odense University Hospital, Denmark (D.M.M., H.M.); Institute of Health and Wellbeing (D.A.M.) and Institute of Clinical Sciences (C.B., G.R.), University of Glasgow, United Kingdom; Norwich Medical School, University of East Anglia, Norwich, United Kingdom (M.F.); Health Research Institute, University of Limerick, Ireland (J.F.); National Health Service, Fife, United Kingdom (S.M.); and William Harvey Research Institute, Queen Mary University of London, United Kingdom (A.D.T.). philip.adamson@ed.ac.uk. 2. From the British Heart Foundation Centre for Cardiovascular Science (P.D.A., A.H., A.S.V.S., T.A.P., N.A.B., E.J.R.v.B., M.R.D., N.L.M., D.E.N.) and Clinical Research Imaging Centre (M.C.W.), University of Edinburgh, United Kingdom; Department of Cardiology, Odense University Hospital, Denmark (D.M.M., H.M.); Institute of Health and Wellbeing (D.A.M.) and Institute of Clinical Sciences (C.B., G.R.), University of Glasgow, United Kingdom; Norwich Medical School, University of East Anglia, Norwich, United Kingdom (M.F.); Health Research Institute, University of Limerick, Ireland (J.F.); National Health Service, Fife, United Kingdom (S.M.); and William Harvey Research Institute, Queen Mary University of London, United Kingdom (A.D.T.).
Abstract
BACKGROUND: We determined whether high-sensitivity cardiac troponin I can improve the estimation of the pretest probability for obstructive coronary artery disease (CAD) in patients with suspected stable angina. METHODS AND RESULTS: In a prespecified substudy of the SCOT-HEART trial (Scottish Computed Tomography of the Heart), plasma cardiac troponin was measured using a high-sensitivity single-molecule counting assay in 943 adults with suspected stable angina who had undergone coronary computed tomographic angiography. Rates of obstructive CAD were compared with the pretest probability determined by the CAD Consortium risk model with and without cardiac troponin concentrations. External validation was undertaken in an independent study population from Denmark comprising 487 patients with suspected stable angina. Higher cardiac troponin concentrations were associated with obstructive CAD with a 5-fold increase across quintiles (9%-48%; P<0.001) independent of known cardiovascular risk factors (odds ratio, 1.35; 95% confidence interval, 1.25-1.46 per doubling of troponin). Cardiac troponin concentrations improved the discrimination and calibration of the CAD Consortium model for identifying obstructive CAD (C statistic, 0.788-0.800; P=0.004; χ2=16.8 [P=0.032] to 14.3 [P=0.074]). The updated model also improved classification of the American College of Cardiology/American Heart Association pretest probability risk categories (net reclassification improvement, 0.062; 95% confidence interval, 0.035-0.089). The revised model achieved similar improvements in discrimination and calibration when applied in the external validation cohort. CONCLUSIONS: High-sensitivity cardiac troponin I concentration is an independent predictor of obstructive CAD in patients with suspected stable angina. Use of this test may improve the selection of patients for further investigation and treatment. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01149590.
BACKGROUND: We determined whether high-sensitivity cardiac troponin I can improve the estimation of the pretest probability for obstructive coronary artery disease (CAD) in patients with suspected stable angina. METHODS AND RESULTS: In a prespecified substudy of the SCOT-HEART trial (Scottish Computed Tomography of the Heart), plasma cardiac troponin was measured using a high-sensitivity single-molecule counting assay in 943 adults with suspected stable angina who had undergone coronary computed tomographic angiography. Rates of obstructive CAD were compared with the pretest probability determined by the CAD Consortium risk model with and without cardiac troponin concentrations. External validation was undertaken in an independent study population from Denmark comprising 487 patients with suspected stable angina. Higher cardiac troponin concentrations were associated with obstructive CAD with a 5-fold increase across quintiles (9%-48%; P<0.001) independent of known cardiovascular risk factors (odds ratio, 1.35; 95% confidence interval, 1.25-1.46 per doubling of troponin). Cardiac troponin concentrations improved the discrimination and calibration of the CAD Consortium model for identifying obstructive CAD (C statistic, 0.788-0.800; P=0.004; χ2=16.8 [P=0.032] to 14.3 [P=0.074]). The updated model also improved classification of the American College of Cardiology/American Heart Association pretest probability risk categories (net reclassification improvement, 0.062; 95% confidence interval, 0.035-0.089). The revised model achieved similar improvements in discrimination and calibration when applied in the external validation cohort. CONCLUSIONS: High-sensitivity cardiac troponin I concentration is an independent predictor of obstructive CAD in patients with suspected stable angina. Use of this test may improve the selection of patients for further investigation and treatment. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01149590.
Authors: Stephan D Fihn; Julius M Gardin; Jonathan Abrams; Kathleen Berra; James C Blankenship; Apostolos P Dallas; Pamela S Douglas; Joanne M Foody; Thomas C Gerber; Alan L Hinderliter; Spencer B King; Paul D Kligfield; Harlan M Krumholz; Raymond Y K Kwong; Michael J Lim; Jane A Linderbaum; Michael J Mack; Mark A Munger; Richard L Prager; Joseph F Sabik; Leslee J Shaw; Joanna D Sikkema; Craig R Smith; Sidney C Smith; John A Spertus; Sankey V Williams Journal: Circulation Date: 2012-11-19 Impact factor: 29.690
Authors: Torbjørn Omland; Marc A Pfeffer; Scott D Solomon; James A de Lemos; Helge Røsjø; Jūratė Šaltytė Benth; Aldo Maggioni; Michael J Domanski; Jean L Rouleau; Marc S Sabatine; Eugene Braunwald Journal: J Am Coll Cardiol Date: 2013-02-13 Impact factor: 24.094
Authors: Susanne Elisabeth Hosbond; Axel Cosmus Pyndt Diederichsen; Lotte Saaby; Lars Melholt Rasmussen; Jess Lambrechtsen; Henrik Munkholm; Niels Peter Rønnow Sand; Oke Gerke; Tina Svenstrup Poulsen; Hans Mickley Journal: Atherosclerosis Date: 2014-07-21 Impact factor: 5.162
Authors: James K Min; Leslee J Shaw; Richard B Devereux; Peter M Okin; Jonathan W Weinsaft; Donald J Russo; Nicholas J Lippolis; Daniel S Berman; Tracy Q Callister Journal: J Am Coll Cardiol Date: 2007-09-04 Impact factor: 24.094
Authors: Anoop S V Shah; Megan Griffiths; Kuan Ken Lee; David A McAllister; Amanda L Hunter; Amy V Ferry; Anne Cruikshank; Alan Reid; Mary Stoddart; Fiona Strachan; Simon Walker; Paul O Collinson; Fred S Apple; Alasdair J Gray; Keith A A Fox; David E Newby; Nicholas L Mills Journal: BMJ Date: 2015-01-21
Authors: Michelle C Williams; Amanda Hunter; Anoop S V Shah; Valentina Assi; Stephanie Lewis; Joel Smith; Colin Berry; Nicholas A Boon; Elizabeth Clark; Marcus Flather; John Forbes; Scott McLean; Giles Roditi; Edwin J R van Beek; Adam D Timmis; David E Newby Journal: J Am Coll Cardiol Date: 2016-04-19 Impact factor: 24.094
Authors: Ian Ford; Anoop S V Shah; Ruiqi Zhang; David A McAllister; Fiona E Strachan; Muriel Caslake; David E Newby; Chris J Packard; Nicholas L Mills Journal: J Am Coll Cardiol Date: 2016-12-27 Impact factor: 24.094
Authors: Tanja Zeller; Hugh Tunstall-Pedoe; Olli Saarela; Francisco Ojeda; Renate B Schnabel; Tarja Tuovinen; Mark Woodward; Allan Struthers; Maria Hughes; Frank Kee; Veikko Salomaa; Kari Kuulasmaa; Stefan Blankenberg Journal: Eur Heart J Date: 2013-10-08 Impact factor: 29.983
Authors: David E Newby; Michelle C Williams; Andrew D Flapan; John F Forbes; Allister D Hargreaves; Stephen J Leslie; Steff C Lewis; Graham McKillop; Scott McLean; John H Reid; James C Sprat; Neal G Uren; Edwin J van Beek; Nicholas A Boon; Liz Clark; Peter Craig; Marcus D Flather; Chiara McCormack; Giles Roditi; Adam D Timmis; Ashma Krishan; Gillian Donaldson; Marlene Fotheringham; Fiona J Hall; Paul Neary; Louisa Cram; Sarah Perkins; Fiona Taylor; Hany Eteiba; Alan P Rae; Kate Robb; Dawn Barrie; Kim Bissett; Adelle Dawson; Scot Dundas; Yvonne Fogarty; Prasad Guntur Ramkumar; Graeme J Houston; Deborah Letham; Linda O'Neill; Stuart D Pringle; Valerie Ritchie; Thiru Sudarshan; Jonathan Weir-McCall; Alistair Cormack; Iain N Findlay; Stuart Hood; Clare Murphy; Eileen Peat; Barbara Allen; Andrew Baird; Danielle Bertram; David Brian; Amy Cowan; Nicholas L Cruden; Marc R Dweck; Laura Flint; Samantha Fyfe; Collette Keanie; Tom J MacGillivray; David S Maclachlan; Margaret MacLeod; Saeed Mirsadraee; Avril Morrison; Nicholas L Mills; Fiona C Minns; Alyson Phillips; Laura J Queripel; Nicholas W Weir; Fiona Bett; Frances Divers; Katie Fairley; Ashok J Jacob; Edith Keegan; Tricia White; John Gemmill; Margo Henry; James McGowan; Lorraine Dinnel; C Mark Francis; Dennis Sandeman; Ajay Yerramasu; Colin Berry; Heather Boylan; Ammani Brown; Karen Duffy; Alison Frood; Janet Johnstone; Kirsten Lanaghan; Ross MacDuff; Martin MacLeod; Deborah McGlynn; Nigel McMillan; Laura Murdoch; Colin Noble; Victoria Paterson; Tracey Steedman; Nikolaos Tzemos Journal: Trials Date: 2012-10-04 Impact factor: 2.279
Authors: Paul Welsh; David Preiss; Anoop S V Shah; David McAllister; Andrew Briggs; Charles Boachie; Alex McConnachie; Caroline Hayward; Sandosh Padmanabhan; Claire Welsh; Mark Woodward; Archie Campbell; David Porteous; Nicholas L Mills; Naveed Sattar Journal: Clin Chem Date: 2018-08-20 Impact factor: 8.327
Authors: Maros Ferencik; Thomas Mayrhofer; Michael T Lu; Daniel O Bittner; Hamed Emami; Stefan B Puchner; Nandini M Meyersohn; Alexander V Ivanov; Elizabeth C Adami; Deepak Voora; Geoffrey S Ginsburg; James L Januzzi; Pamela S Douglas; Udo Hoffmann Journal: JACC Cardiovasc Imaging Date: 2022-05-11
Authors: Rong Bing; James Henderson; Amanda Hunter; Michelle C Williams; Alastair J Moss; Anoop S V Shah; David A McAllister; Marc R Dweck; David E Newby; Nicholas L Mills; Philip D Adamson Journal: Heart Date: 2019-06-01 Impact factor: 5.994
Authors: Mirthe Dekker; Farahnaz Waissi; Nathalie Timmerman; Max J M Silvis; Leo Timmers; Dominique P V de Kleijn Journal: Int J Mol Sci Date: 2020-11-30 Impact factor: 5.923
Authors: Kuan Ken Lee; Anda Bularga; Rachel O'Brien; Amy V Ferry; Dimitrios Doudesis; Takeshi Fujisawa; Shauna Kelly; Stacey Stewart; Ryan Wereski; Denise Cranley; Edwin J R van Beek; David J Lowe; David E Newby; Michelle C Williams; Alasdair J Gray; Nicholas L Mills Journal: J Am Coll Cardiol Date: 2021-10-05 Impact factor: 24.094
Authors: Jeffrey Netto; Andrej Teren; Ralph Burkhardt; Anja Willenberg; Frank Beutner; Sylvia Henger; Gerhard Schuler; Holger Thiele; Berend Isermann; Joachim Thiery; Markus Scholz; Thorsten Kaiser Journal: Nutrients Date: 2022-08-20 Impact factor: 6.706